What's going on with the Medibank share price today?

Shareholders will be happy to see Medibank shares drop in value today.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) seems to be gearing up for another tough day this Thursday. At the time of writing, the ASX 200 has slipped by 0.16% leaving the index at around 7,650 points. But let's talk about what's going on with the Medibank Private Ltd (ASX: MPL) share price.

On the surface, it looks as though Medibank shares are having an awful time today thus far. The private health insurance provider closed at $3.66 a share yesterday. But those same shares opened at $3.60 this morning, where they remain at present. That's a loss worth 1.64%.

Upon deeper inspection though, investors should be happy with this share price drop. That's because it is a consequence of Medibank shares trading ex-dividend today.

Last week, we covered Medibank's latest half-year earnings report, covering the six months to 31 December. As we discussed at the time, it was a fairly positive report card from Medibank Private.

The company announced that its revenue for the period rose by 3.3% up to $4.02 billion. Underlying profits rose by an even better 16.3% to $262.5 million, which enabled Medibank to unveil an interim dividend of 7.2 cents per share, fully franked, for the half-year.

This was a big announcement for the company. Firstly, this new dividend of 7.3 cents per share was a 14.3% rise over last year's interim dividend of 6.3 cents per share.

But this new payout is also set to be the largest interim dividend Medibank has ever paid out in its history as a public company. It takes Medibank's full-year payouts from 14.6 cents per share to 15.5 cents. That's including the final dividend of 8.3 cents per share that we saw last October.

private health insurance diagram.

Image source: Getty Images

Why are Medibank shares dropping this Thursday?

As we warned on Tuesday, yesterday was the last day you could have bought Medibank shares with the rights to receive this dividend attached.

Today, the company has just traded ex-dividend.

When a company trades ex-dividend, it cuts off new investors from eligibility for an upcoming shareholder payment. This means that Medibank shares have just become slightly less valuable, given new investors from today will have to wait until Medibank's second dividend of 2024 to start receiving income from the company.

So the resulting fall in share price that we are witnessing today is completely normal.

For eligible investors, Medibank's latest dividend is scheduled to arrive in bank accounts next month on 20 March.

At the current Medibank Private share price, this ASX 200 health insurer is trading on a dividend yield of 4.31%.

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Five healthcare workers standing together and smiling.
Healthcare Shares

3 ASX 200 healthcare shares to buy amid sector rout

The experts are backing these stocks for price growth.

Read more »

Researchers and doctors with futuristic 3D hologram overlay for body anatomy or DNA in hospital clinic.
Healthcare Shares

Are investors taking a big gamble chasing 4DX shares higher and higher?

Investor interest in this ASX healthcare tech stock is booming.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

Half a man's face from the nose up peers over a table.
Healthcare Shares

If I could buy only 1 ASX 200 share right now, it would be…

This stock looks underpriced and oversold to me.

Read more »

woman testing substance in laboratory dish, csl share price
Healthcare Shares

CSL shares slide again in March — but is a comeback brewing?

Brokers remain upbeat and see upside up to 95% for the biotech stock.

Read more »

A female athlete in green spandex leaps from one cliff edge to another representing 3 ASX shares that are destined to rise and be great
Broker Notes

Up 57% since February, why Telix shares could keep leaping higher in 2026

A leading analyst believes investors are undervaluing Telix shares. But why?

Read more »

A woman has a thoughtful look on her face as she studies a fan of Australian 20 dollar bills she is holding on one hand while he rest her other hand on her chin in thought.
Healthcare Shares

Is it time to get greedy with CSL shares?

This ASX healthcare giant is out of favour, but that may be where opportunity starts.

Read more »

Stressed, unhappy, and tired scientist with a headache working on a computer in a lab.
Healthcare Shares

3 ASX 200 healthcare shares at multi-year lows

Does this present a buying opportunity?

Read more »